Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma

12 Jan 2023

Abstract excerpt

BACKGROUND: Lung adenocarcinoma (LUAD) is characterized by high morbidity and mortality rates and poor prognosis. N7-methylguanosine play an increasingly vital role in lung adenocarcinoma. However, the prognostic value of N7-methylguanosine related-miRNAs in lung adenocarcinoma remains unclear. METHODS: In the study, the mRNA and miRNA expression profiles and corresponding clinical informations were downloaded...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36635678
DOI: 10.1186/s12890-022-02290-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinomaPMID 36635678Read ↗

A Noval Prognostic Signature of the N7-Methylguanosine (m7G)-Related miRNA in Lung Adenocarcinoma Running title: Prognostic Signature of m7G Related miRNA in Lung AdenocarcinomaSemantic proximity Read ↗

Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung AdenocarcinomaSemantic proximity Read ↗

Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinomaSemantic proximity Read ↗

A Prognostic Risk Score Based on Genes related with m 7 G regulators for the Prognosis and Immunotherapy Response of Lung AdenocarcinomaSemantic proximity Read ↗

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinomaSemantic proximity Read ↗

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung AdenocarcinomaSemantic proximity Read ↗

An RNA Modification–Associated Gene-Based Prognostic Model and Its Relevance to the Immune Microenvironment and Therapeutic Response in Lung AdenocarcinomaSemantic proximity Read ↗

Deciphering N6‐Methyladenosine‐Related Genes Signature to Predict Survival in Lung AdenocarcinomaSemantic proximity Read ↗

Prognostic signature of lung adenocarcinoma based on stem cell-related genesSemantic proximity Read ↗

M6a Regulator-Mediated RNA Methylation modification Patterns Correlated With Prognosis Value and Immune Response in Adenocarcinoma of lungSemantic proximity Read ↗

M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinomaSemantic proximity Read ↗

Characteristic of Classification and Prognostic Scoring Based on M6a RNA Methylation Modification in Lung Adenocarcinoma and Tumor Microenvironment AssociationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.